DHPA

  • Home
  • About Us
    • Leadership
      • Executive Committee
      • Board Members
    • DHPA Members
    • Contact Us
    • Join Us
  • Advocacy
    • Patient Access to Independent GI Care
      • Colorectal Cancer Screening
    • Diversity Equity and Inclusion
    • Modernizing the Stark Law
    • Saving the IOASE
    • Pathology Services Utilization
  • Resources
    • Independent GI Careers
    • Research
    • Fact Sheets
    • Letters to Policymakers
  • Newsroom
    • Press Releases
    • DHPA in the News
    • GI News Round Up

July 16, 2018

DHPA Submits Comments in Response to HHS RFI on “Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs”

DHPA has submitted comments to the U.S. Health and Human Services Request for Information entitled “Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs.”

In the comment letter, DHPA focuses on several of the key initiatives highlighted in the RFI:

  • DHPA supports site neutrality for physician-administered drugs across the hospital and independent physician practice settings in order to promote competition and reduce the overall cost of care for the Medicare system and beneficiaries.
  • DHPA supports reform of the 340B drug discount program to address the program’s anti-competitive nature and to ensure that low-income and uninsured patients benefit from the program.
  • Consistent with the President’s commitment to “put American patients first,” DHPA cannot support a shift of drugs from Medicare Part B to Medicare Part D. Moving drugs from Part B to Part D would not achieve the Administration’s goals of improving health outcomes, lowering out-of-pocket costs, and decreasing total cost of care.
  • For similar reasons, DHPA is concerned about the repercussions of HHS relaunching a Competitive Acquisition Program (“CAP”) for Part B drugs. If such a program were re-introduced, physician participation should be voluntary and substantial guardrails would need to be put in place to ensure that CAP vendors do not interfere in the physician-patient relationship.

Click here to read DHPA’s full comment letter.

Filed Under: Letters to Policymakers, Newsroom, Press Releases, Protecting Patient Access to Integrated GI Care in the Independent Setting

Member Spotlight

For more than 30 years, Akron Digestive Disease Consultants has been providing care for conditions affecting the esophagus, stomach, intestines, colon, liver, pancreas, and gall bladder. The practice currently has five board certified physicians committed to providing outstanding personalized and timely digestive health care.

Learn more at:
www.akrondigestive.com

Become a Member

    Is your practice interested in promoting and preserving accessible, high quality and cost-efficient care in the independent GI medical setting? Contact us today about joining DHPA.

    Recent News

    • Dr. Latha Alaparthi Named President & Board Chair of DHPA

    • Independent Healthcare Grants and Charitable Donations (Abbvie)

    • Community Grant Program (Walmart Foundation)

    • High School Outreach Curriculum and Blueprint for Session Titled: The Tools of a Gastroenterology Practice (Capital Digestive Care)

    • Pioneering Ideas: Exploring the Future to Build a Culture of Health (Robert Wood Johnson Foundation)

    • DHPA Requests Safe Harbor for Copay Coupons for Drugs with no Lower-Cost Alternative

    • Provider Groups to GOP Healthy Futures Task Force: Site Neutral Payment Reform Key to Reducing Anti-Competitive Consolidation

    • Inflammatory Bowel Disease Infographic in English and Spanish

    • Race-Based Clinical Recommendations in Gastroenterology (AGA)

    Digestive Health Physicians Association, Inc.
    10770 Columbia Pike, Suite 400
    Silver Spring, Maryland, 20901
    © 2020 DHPA

    Follow @DHPAnews
    Tweets by DHPAnews

    Copyright © 2022 · Executive Pro Theme on Genesis Framework · WordPress · Log in